A $2B delay — What ASCs, hospitals are missing out on when shutting down joint replacement programs

It's believed that COVID-19-related elective surgery cancellations at hospitals and ASCs cost both facilities around $5 billion in lost revenue, a Kaiser Health News analysis published in Fortune concludes.

What you should know:

1. U.S. hospitals collect an annual market value between $15.5 billion and $21.5 billion for knee replacements. Hip replacements, which make up about half the volume of knee replacements, increase the total annual value to between $23 billion and $32 billion.

2. For every month a hospital or ASC shut down their knee replacement program, they lose between $1.3 billion and $1.8 billion; adding in hip replacements increases that figure to between $1.9 billion and $2.7 billion.

3. Hip and knee replacement rates more than doubled from 2000 to 2015, and with knee replacement rates expected to triple between 2020 and 2040.

More articles on specialty care:
ASC considers in-house alternative to 'overwhelmed' hospital testing center — 3 insights
425 surgery centers that received PPP funds of more than $150K by state
4 COVID-19 testing insights for ASCs

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers